Filing Flows › Niagen Bioscience (NAGE) › Net income
Niagen Bioscience (NAGE) net income by quarter
Niagen Bioscience's net income was $963K in Q2 2026 (second quarter 2026), -85% from Q1 2026. Over the last 6 quarters it ranged from $963K (Q2 2026) to $6.3M (Q1 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $963K | -85% | -73% |
| Q1 2026 | $6.3M | +53% | +25% |
| Q4 2025 | $4.1M | -10% | — |
| Q3 2025 | $4.6M | +27% | — |
| Q2 2025 | $3.6M | -29% | — |
| Q1 2025 | $5.1M | — | — |
Q2 2026 at a glance
Niagen Bioscience, Q2 2026: revenue $29.8M (-4% year over year), operating margin 2.4%, net earnings $963K, operating cash flow $2.8M. The chart follows the revenue to costs, profit and cash.
Questions
What is Niagen Bioscience's net income?
Niagen Bioscience's net income was $963K in Q2 2026 (second quarter 2026), -85% from Q1 2026.
How has Niagen Bioscience's net income changed?
Over the last 6 quarters it ranged from $963K (Q2 2026) to $6.3M (Q1 2026).